Astellas
Astellas Trains Sights On Iveric Bio In $5.9 Bi...
Astellas Pharma EMEA celebrates its 10th annive...
Astellas Pharma to acquire Propella Therapeutic...
Astellas Pharma Inc. (4503N.MX) stock price, ne...
Astellas Pharmaceuticals Establishes Open Innov...
Главная | Astellas Pharma Russia
FDA blocks Astellas’ Claudin cancer drug over m...
Astellas Home page | Astellas Pharma Inc.
Astellas licenses 4DMT’s AAV vector for ophthal...
Astellas Pharma Projects :: Photos, videos, log...
About | Astellas Pharma Ltd
Astellas Offloads 5 Legacy Products to Germany’...
Home | Astellas Pharma Canada, Inc.
US FDA approves Astellas Pharma pill for menopa...
FDA Approves Astellas’ Non-hormonal Menopause T...
Astellas Pharma
Astellas Pharma on LinkedIn: 医薬品の枠を超えた...
Astellas introduces sustainable community initi...
Pharmaceutical Technology
Japan's Astellas sees cancer drug fueling 29% p...
Astellas Pharma: A Contrarian Investment (OTCMK...
Astellas gets FDA priority review for gastric c...
FDA Grants Full Approval for Astellas Pharma's ...
Astellas' Prostate Cancer Drug Available In Jap...
Asia Business Daily on Twitter: "Astellas Pharm...
Astellas Pharma - Global Web Site on Behance
Атлас лекарственных растений - YouTube
Astellas, University of Tokyo extend partnershi...
Astellas Sues Over New Myrbetriq Patent to Reca...
Astellas Pharma US on LinkedIn: FDA Grants Prio...
China Formally Arrests Japanese Employee of Dru...
Astellas Pharma Joins Record Bond Sales by Japa...